# Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)

> **NCT02147067** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 26 (actual)

## Conditions studied

- Microvascular Angina

## Interventions

- **DRUG:** Ranolazine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02147067
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2018-03
- **Final completion:** 2018-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02147067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02147067, "Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02147067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*